Use of PK-PD modelling to predict the impact of non-compliance
Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
StandardStandard
Use of PK-PD modelling to predict the impact of non-compliance. / Hughes, D.; Hughes, D.A.
2003. Papur a gyflwynwyd yn South West Clinical Pharmacology Group, Liverpool, UK.
2003. Papur a gyflwynwyd yn South West Clinical Pharmacology Group, Liverpool, UK.
Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
HarvardHarvard
Hughes, D & Hughes, DA 2003, 'Use of PK-PD modelling to predict the impact of non-compliance', Papur a gyflwynwyd yn South West Clinical Pharmacology Group, Liverpool, UK, 3/01/01.
APA
Hughes, D., & Hughes, D. A. (2003). Use of PK-PD modelling to predict the impact of non-compliance. Papur a gyflwynwyd yn South West Clinical Pharmacology Group, Liverpool, UK.
CBE
Hughes D, Hughes DA. 2003. Use of PK-PD modelling to predict the impact of non-compliance. Papur a gyflwynwyd yn South West Clinical Pharmacology Group, Liverpool, UK.
MLA
Hughes, D. a D.A. Hughes Use of PK-PD modelling to predict the impact of non-compliance. South West Clinical Pharmacology Group, Liverpool, UK, 03 Ion 0001, Papur, 2003.
VancouverVancouver
Hughes D, Hughes DA. Use of PK-PD modelling to predict the impact of non-compliance. 2003. Papur a gyflwynwyd yn South West Clinical Pharmacology Group, Liverpool, UK.
Author
RIS
TY - CONF
T1 - Use of PK-PD modelling to predict the impact of non-compliance
AU - Hughes, D.
AU - Hughes, D.A.
PY - 2003/11/1
Y1 - 2003/11/1
M3 - Paper
T2 - South West Clinical Pharmacology Group, Liverpool, UK
Y2 - 3 January 0001
ER -